Predictions
Johnson & Johnson
Start price
Target price
Perf. (%)
€153.36
24.01.23
24.01.23
€160.00
24.01.24
24.01.24
-4.60%
25.01.24
25.01.24
Could be worthwhile Investment >10% per year
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€68.08
03.01.23
03.01.23
-
03.01.24
03.01.24
-32.29%
28.12.23
28.12.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Amgen Inc.
Start price
Target price
Perf. (%)
€247.05
26.12.22
26.12.22
€255.00
26.12.23
26.12.23
-0.10%
19.09.23
19.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€100.60
08.11.22
08.11.22
€150.00
31.01.25
31.01.25
5.77%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€370.05
04.11.22
04.11.22
€610.00
04.11.23
04.11.23
44.17%
05.11.23
05.11.23
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€758.30
01.11.22
01.11.22
€900.00
01.11.23
01.11.23
-9.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€362.80
29.10.22
29.10.22
€400.00
29.10.23
29.10.23
6.95%
05.05.23
05.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.68
28.10.22
28.10.22
-
28.10.23
28.10.23
-7.17%
18.05.23
18.05.23
Risky Investment
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€301.55
28.10.22
28.10.22
-
28.10.23
28.10.23
-10.79%
01.01.23
01.01.23
Risky Investment
Pfizer Inc.
Start price
Target price
Perf. (%)
€44.90
18.10.22
18.10.22
-
18.11.26
18.11.26
-44.54%
11.03.24
11.03.24
Probably not worthwhile Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€67.38
13.10.22
13.10.22
€46.00
13.10.23
13.10.23
9.44%
14.10.23
14.10.23
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.55
13.10.22
13.10.22
-
-
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Biogen Inc.
Start price
Target price
Perf. (%)
€272.50
30.09.22
30.09.22
€400.00
31.12.24
31.12.24
4.59%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Biogen Inc.
Start price
Target price
Perf. (%)
€204.55
24.09.22
24.09.22
-
24.09.23
24.09.23
37.28%
18.05.23
18.05.23
Risky Investment
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.36
19.09.22
19.09.22
€130.00
19.09.23
19.09.23
-8.59%
20.09.23
20.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€309.00
15.09.22
15.09.22
€550.00
15.09.23
15.09.23
74.76%
16.09.23
16.09.23
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€69.37
07.09.22
07.09.22
€100.00
31.12.25
31.12.25
-12.07%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€285.85
07.09.22
07.09.22
€400.00
31.12.25
31.12.25
10.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€312.95
07.09.22
07.09.22
€450.00
31.12.25
31.12.25
24.24%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€90.50
24.08.22
24.08.22
€120.00
24.08.23
24.08.23
17.79%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year